Idiopathic hemolytic-uremic syndrome (HUS).
نویسندگان
چکیده
منابع مشابه
Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement
In typical hemolytic uremic syndrome (HUS) approximately 25% of patients show central nervous system (CNS) involvement often leading to serious long-term disabilities. We used the C5-complement inhibitor Eculizumab as rescue therapy. From 2011 to 2014, 11 children (median age 22 months, range 11-175) with enterohemorrhagic Escherichia coli-positive HUS requiring dialysis who had seizures (11/11...
متن کاملHemolytic-Uremic Syndrome (HUS) in Children — Causes and Treatment
Hemolytic–uremic syndrome (HUS) consists of a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal insufficiency (failure), with severity ranging from subclinical to life threatening. HUS, based on an etiological agent, can be classified into classic or STEC-HUS and atypical HUS. HUS is a common cause of acute renal failure in the pediatric population. In this article, ...
متن کاملHemolytic-Uremic Syndrome (HUS) in Children — Causes and Treatment
Hemolytic–uremic syndrome (HUS) consists of a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal insufficiency (failure), with severity ranging from subclinical to life threatening. HUS, based on an etiological agent, can be classified into classic or STEC-HUS and atypical HUS. HUS is a common cause of acute renal failure in the pediatric population. In this article, ...
متن کاملHemolytic-Uremic Syndrome (HUS) in Children — Causes and Treatment
Hemolytic–uremic syndrome (HUS) consists of a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal insufficiency (failure), with severity ranging from subclinical to life threatening. HUS, based on an etiological agent, can be classified into classic or STEC-HUS and atypical HUS. HUS is a common cause of acute renal failure in the pediatric population. In this article, ...
متن کاملAtypical hemolytic uremic syndrome
Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy (TMA) characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Most cases of aHUS are caused by uncontrolled complement activation due to genetic mutations in the alternative pathway of complement. More recently, mutations in the gene of coagulation system have also been identified in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nihon Naika Gakkai Zasshi
سال: 2006
ISSN: 0021-5384,1883-2083
DOI: 10.2169/naika.95.2090